OUR FIRST PROGRAM

NIEMANN-PICK DISEASE, TYPE C

Cholesterol accumulation in the lysosome is the central pathogenic driver of NPC.

How Cholesterol Flows
Neurons need cholesterol to maintain signaling, membrane health, and the myelin sheath. After they take in cholesterol produced by other cells in the brain, the cholesterol moves to the lysosome. Inside the lysosome, the NPC2 protein picks up cholesterol and transfers it to NPC1, a large protein that crosses the lysosomal membrane and moves cholesterol out to the rest of the cell where it can continue to flow where it is needed.

What Happens When Cholesterol Transport is Blocked
NPC occurs when variants in either NPC1 or NPC2 genes result in dysfunctional NPC1 or NPC2 proteins that can no longer traffic cholesterol out of the lysosome. Cholesterol accumulates in the lysosome and is depleted from other parts of the cell that need it to maintain healthy function, resulting in neuroinflammation, synaptic dysfunction, and neuronal loss. Restoring the trafficking of cholesterol can address the central pathogenic driver of disease.

Disease Severity Depends on the Level of Cholesterol Disruption
Hundreds of pathogenic variants in the NPC1 and NPC2 genes can lead to NPC. Variants that preserve more function of the NPC proteins tend to cause later-onset disease with slower progression. More severe variants cause earlier neurological onset, faster cholesterol accumulation, and more rapid progression. Infantile-onset NPC (I-NPC), with age of neurological onset before the age of 6, accounts for about half of all NPC diagnoses. 

NPC can look different in every child
Because cholesterol transport affects so many cell types, NPC can show up in many ways, and its early signs often overlap with more common conditions. An enlarged liver and/or spleen is one of the most common findings across patients with NPC, but two children with the disease may have very different early symptoms. This variety is one reason diagnosis often takes years, and why testing guided by clinical criteria matters.

Learn more about the signs of NPC and testing eligibility:

ABOUT NPC

  • Niemann-Pick disease, type C (NPC) is a rare, progressive, genetic disorder that results from pathogenic variants in the NPC1 or NPC2 genes that lead to impaired cholesterol trafficking out of lysosomes.
  • Accumulation of cholesterol in the lysosomes impacts cellular function, affecting every cell in the body.
  • This disruption of cholesterol trafficking is most devastating in the brain and nervous system, driving progressive neurological decline and increased neuronal cell death. NPC can also affect the liver, spleen, and lungs.
  • Infantile onset NPC (I-NPC) is the most aggressive form of the disease, with neurological symptom onset before the age of 6.
  • Disease presentation is heterogeneous and frequently missed during early stages where intervention can have the biggest impact.

Learn more and find resources for patients and families: